Matrix metalloproteinase 3 facilitates colorectal cancer progression by enhancing cell proliferation and invasion
World Journal of Gastroenterology · 21.09.2026 · 32 (35)
DOI: 10.3748/wjg.119277 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 21.09.2026. Verfasst von Bin-Bin Du und 3 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Matrix metalloproteinase 3 (MMP3) plays critical roles in tumor progression, but its function in colorectal cancer (CRC) remains incompletely understood. AIM To investigate MMP3 expression, its clinical significance, and molecular mechanisms in CRC. METHODS The Cancer Genome Atlas colon adenocarcinoma and rectal adenocarcinoma datasets were analyzed for MMP3 mRNA levels, which were then validated in 40 paired CRC tumor and adjacent normal tissues (via quantitative real-time-PCR) and 90 CRC cases (via immunohistochemistry). Clinicopathological correlation analysis and Kaplan-Meier survival analysis were performed. The biological functions of MMP3 were assessed using gain-and loss-of-function assays in CRC cell lines (SW480, SW620, HT-29, HCT116, LOVO) and the normal human colonic epithelial cell line NCM460. 4D-data independent acquisition proteomics was used to identify downstream targets of MMP3, which were validated by quantitative real-time-PCR and xenograft models. RESULTS MMP3 was significantly upregulated in CRC tissues compared with normal tissues and correlated with advanced tumor size, nerve invasion, T stage, lymph node metastasis, tumor-node-metastasis stage, and poor 5-year overall survival. MMP3 knockdown inhibited CRC cell proliferation, colony formation, migration, and invasion, while promoting apoptosis; MMP3 overexpression exerted the opposite effects. Proteomic analysis identified endothelial PAS domain protein 1 (EPAS1) as a key downstream target of MMP3. In CRC xenograft models, MMP3 silencing reduced EPAS1 expression and suppressed tumor growth. CONCLUSION Our findings demonstrate that MMP3 promotes CRC progression by regulating EPAS1, highlighting MMP3 as a potential prognostic biomarker and therapeutic target for CRC.
Zitieren
APA
Du, B., Qian, Z., Zhu, C., & Guan, Q. (2026). Matrix metalloproteinase 3 facilitates colorectal cancer progression by enhancing cell proliferation and invasion. World Journal of Gastroenterology, 32(35). https://doi.org/10.3748/wjg.119277
Vancouver
Du B, Qian Z, Zhu C, Guan Q. Matrix metalloproteinase 3 facilitates colorectal cancer progression by enhancing cell proliferation and invasion. World Journal of Gastroenterology. 2026;32(35). doi:10.3748/wjg.119277
BibTeX
@article{Du2026,
author = {Du, Bin-Bin and Qian, Zheng-Peng and Zhu, Cheng-Zhang and Guan, Quan-Lin},
title = {Matrix metalloproteinase 3 facilitates colorectal cancer progression by enhancing cell proliferation and invasion},
journal = {World Journal of Gastroenterology},
year = {2026},
volume = {32},
number = {35},
doi = {10.3748/wjg.119277}
}
EUVIMED